Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.
Enable Medicine has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
Enable Medicine's investors include General Catalyst, Presight Capital, Initialized Capital, Anthos Capital, Breyer Capital.
Enable Medicine is headquartered in Menlo Park, United States.
Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.
Enable Medicine is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enable Medicine — Funding & Investors." VCBacked, April 7, 2022, https://www.vcbacked.co/company/enable-medicine. Accessed September 30, 2026.
VCBacked. (2022). Enable Medicine — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/enable-medicine
{{cite web |title=Enable Medicine — Funding & Investors |url=https://www.vcbacked.co/company/enable-medicine |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated